TY - JOUR
T1 - Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents
T2 - An optical coherence tomography and intravascular ultrasound study
AU - Radu, Maria D.
AU - Räber, Lorenz
AU - Kalesan, Bindu
AU - Muramatsu, Takashi
AU - Kelbæk, Henning
AU - Heo, Jungho
AU - Jørgensen, Erik
AU - Helqvist, Steffen
AU - Farooq, Vasim
AU - Brugaletta, Salvatore
AU - Garcia-Garcia, Hector M.
AU - Jüni, Peter
AU - Saunamäki, Kari
AU - Windecker, Stephan
AU - Serruys, Patrick W.
N1 - Funding Information:
This work was supported by the following funding: M.D.R has received research grants from The Heart Centre Rigshospitalet Research Foundation and Copenhagen University. Part of the analysis was funded by intramural grants provided by CTU Bern, Bern University Hospital, the Institute of Social and Preventive Medicine, University of Bern, and a grant to S.W., P.J., L.R. (SPUM) from the Swiss National Science Foundation (Grant 33CM30-124112).
PY - 2014/3
Y1 - 2014/3
N2 - ObjectivesThe purpose of this study was to assess the occurrence, predictors, and mechanisms of optical coherence tomography (OCT)-detected coronary evaginations following drug-eluting stent (DES) implantation. BackgroundAngiographic ectasias and aneurysms in stented segments have been associated with a risk of late stent thrombosis. Using OCT, some stented segments show coronary evaginations reminiscent of ectasias.MethodsEvaginations were defined as outward bulges in the luminal contour between struts. They were considered major evaginations (MEs) when extending ≥3 mm along the vessel length, with a depth ≥10% of the stent diameter. A total of 228 patients who had sirolimus (SES)-, paclitaxel-, biolimus-, everolimus (EES)-, or zotarolimus (ZES)-eluting stents implanted in 254 lesions, were analysed after 1, 2, or 5 years; and serial assessment using OCT and intravascular ultrasound (IVUS) was performed post-intervention and after 1 year in 42 patients.ResultsMajor evaginations occurred frequently at all time points in SES (∼26%) and were rarely seen in EES (3%) and ZES (2%, P = 0.003). Sirolimus-eluting stent implantation was the strongest independent predictor of ME [adjusted OR (95% CI) 9.1 (1.1-77.4), P = 0.008]. Malapposed and uncovered struts were more common in lesions with vs. without ME (77 vs. 25%, P < 0.001 and 95 vs. 20%, P < 0.001, respectively) as was thrombus [49 vs. 14%, OR 7.3 (95% CI: 1.7-31.2), P = 0.007]. Post-intervention intra-stent dissection and protrusion of the vessel wall into the lumen were associated with an increased risk of evagination at follow-up [OR (95% CI): 2.9 (1.8-4.9), P < 0.001 and 3.3 (1.6-6.9), P = 0.001, respectively]. In paired IVUS analyses, lesions with ME showed a larger increase in the external elastic membrane area (20% area change) compared with lesions without ME (5% area change, P < 0.001).ConclusionOptical coherence tomography-detected MEs are a specific morphological footprint of early-generation SES and are nearly absent in newer-generation ZES and EES. Evaginations appear to be related to vessel injury at baseline; are associated with positive vessel remodelling; and correlate with uncoverage, malapposition, and thrombus at follow-up.
AB - ObjectivesThe purpose of this study was to assess the occurrence, predictors, and mechanisms of optical coherence tomography (OCT)-detected coronary evaginations following drug-eluting stent (DES) implantation. BackgroundAngiographic ectasias and aneurysms in stented segments have been associated with a risk of late stent thrombosis. Using OCT, some stented segments show coronary evaginations reminiscent of ectasias.MethodsEvaginations were defined as outward bulges in the luminal contour between struts. They were considered major evaginations (MEs) when extending ≥3 mm along the vessel length, with a depth ≥10% of the stent diameter. A total of 228 patients who had sirolimus (SES)-, paclitaxel-, biolimus-, everolimus (EES)-, or zotarolimus (ZES)-eluting stents implanted in 254 lesions, were analysed after 1, 2, or 5 years; and serial assessment using OCT and intravascular ultrasound (IVUS) was performed post-intervention and after 1 year in 42 patients.ResultsMajor evaginations occurred frequently at all time points in SES (∼26%) and were rarely seen in EES (3%) and ZES (2%, P = 0.003). Sirolimus-eluting stent implantation was the strongest independent predictor of ME [adjusted OR (95% CI) 9.1 (1.1-77.4), P = 0.008]. Malapposed and uncovered struts were more common in lesions with vs. without ME (77 vs. 25%, P < 0.001 and 95 vs. 20%, P < 0.001, respectively) as was thrombus [49 vs. 14%, OR 7.3 (95% CI: 1.7-31.2), P = 0.007]. Post-intervention intra-stent dissection and protrusion of the vessel wall into the lumen were associated with an increased risk of evagination at follow-up [OR (95% CI): 2.9 (1.8-4.9), P < 0.001 and 3.3 (1.6-6.9), P = 0.001, respectively]. In paired IVUS analyses, lesions with ME showed a larger increase in the external elastic membrane area (20% area change) compared with lesions without ME (5% area change, P < 0.001).ConclusionOptical coherence tomography-detected MEs are a specific morphological footprint of early-generation SES and are nearly absent in newer-generation ZES and EES. Evaginations appear to be related to vessel injury at baseline; are associated with positive vessel remodelling; and correlate with uncoverage, malapposition, and thrombus at follow-up.
KW - Coronary evaginations
KW - Early-generation drug-eluting stents
KW - Intravascular ultrasound
KW - Malapposition
KW - Newer-generation drug-eluting stents
KW - Optical coherence tomography
KW - Positive remodelling
KW - Uncovered stent struts
UR - http://www.scopus.com/inward/record.url?scp=84896908771&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84896908771&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/eht344
DO - 10.1093/eurheartj/eht344
M3 - Article
C2 - 24132187
AN - SCOPUS:84896908771
SN - 0195-668X
VL - 35
SP - 795
EP - 807
JO - European heart journal
JF - European heart journal
IS - 12
ER -